Inpart
Founded in 2001, Inpart (formerly Inova) is a publisher of SaaS platforms dedicated to partnership between the pharmaceutical industry and biotech, for the development of scientific and medical innovations. Based in Lyon, and established in the United Kingdom, Germany and the United States, the company has developed a set of complementary solutions for pharmaceutical laboratories, biotech start-ups and universities and other players in the scientific world.
- Deal: CRM solution to centralize data, ensure compliance and facilitate the efficiency of biopharma partnership projects;
- Connect: platform allowing academic institutes, researchers, businesses and investors to connect with each other with a view to forming partnerships;
Event Data solution: technological platform for connecting and smart scheduling in order to maximize the ROI of attendance at pharmaceutical industry exhibitions.
- 30/10/2023
Inova unveils its new name: Inpart, short for Innovative Partnerships
Inova unveils its new name: Inpart, an abbreviation for Innovative Partnerships which reflects the evolution of partnership practices driven by the ...
- 11/02/2022
Inova acquires IN-PART, a meeting platform for collaboration between academia and industry
Inova acquires IN-PART, a meeting platform for collaboration between academia and industry. Lyon, France, 8 ...
- 19/01/2022
Inova completes the acquisition of the European leader in biotechnology media, Labiotech
Lyon, France, January 18, 2022 – Inova, a leading platform in the world of partnering for biopharmaceutical players, completes the acquisition of Labiotech, the leading media dedicated to biotechnology in Europe. This ...
- 04/08/2021
[VIDEO]: Entrepreneurial voices, Gilles Toulemonde - CEO & Co-Founder of Inova
?? On July 1, Inova announced a significant fundraising alongside The Carlyle Group and NextStage to accelerate its development.Find ...
- 01/07/2021
NextStage AM reaffirms its support for Inova on the occasion of a growth capital transaction led by The Carlyle Group
NextStage AM reaffirms its support for Inova on the occasion of a growth capital transaction led by The Carlyle Group Lyon, ...- 28/09/2018
Inova Software raises 6 million to help pharma collaborate better
Find this news on: https://business.lesechos.fr/entrepreneurs/financer-sa-creation/0302313257422-inova-software-et-nextstage-am-al-assaut-de-l-industrie-pharmaceutique-323681.php-
Digital
-
Smart health
-
Green growth
-
Economy on demand
-
Industrial Internet
Gilles Toulemonde
CEO and co-founderGilles, CEO of Inpart (formerly Inova), directly founded the company after graduating from the Paris School of Mines.
David Carteret
CSO – Chief Scientist OfficerDavid began his career with experience in software development and is now responsible for the technical developments of the company.
Nicolas de Saint Etienne
Deputy General Director